Live Breaking News & Updates on Nasdaq Txmd

Stay updated with breaking news from Nasdaq txmd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research note released on Thursday. The firm issued a hold rating on the stock. TherapeuticsMD Trading Down 0.5 % Shares of TXMD opened at $1.86 on Thursday. The stock has a fifty day moving average of $2.22 and a two-hundred day moving […] ....

United States , Mayne Pharma , Therapeuticsmd Inc , Therapeuticsmd Company Profile , Exchange Commission , Capital Management , Free Report , Get Free Report , Nasdaq Txmd , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)

StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report sent to investors on Monday. The firm issued a hold rating on the stock. TherapeuticsMD Trading Down 0.9 % TherapeuticsMD stock opened at $2.23 on Monday. The business’s 50-day simple moving average is $2.31 and its two-hundred day simple moving […] ....

United States , Mayne Pharma , Therapeuticsmd Company Profile , Therapeuticsmd Inc , Principal Financial Group Inc , Charles Schwab Investment Management Inc , Free Report , Street Corp , Financial Group , Schwab Investment Management , Rhumbline Advisers , Get Free Report , Nasdaq Txmd , Initiated Coverage , Stocknews Com ,

TherapeuticsMD (NASDAQ:TXMD) Receives New Coverage from Analysts at StockNews.com

Research analysts at StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Get Free Report) in a research note issued to investors on Monday. The firm set a “hold” rating on the stock. TherapeuticsMD Stock Performance Shares of NASDAQ:TXMD opened at $2.27 on Monday. TherapeuticsMD has a twelve month low of $1.95 and a twelve […] ....

United States , Marland Walker , Mayne Pharma , Therapeuticsmd Inc , Capital Management , Goldman Sachs Group Inc , Royal Bank , Renaissance Technologies , Tejara Capital Ltd , Get Free Report , Sachs Group , Capital Ltd , Nasdaq Txmd , Initiated Coverage , Stocknews Com ,

TherapeuticsMD (NASDAQ:TXMD) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a report released on Tuesday morning. The brokerage issued a hold rating on the stock. TherapeuticsMD Stock Up 0.9 % NASDAQ TXMD opened at $2.26 on Tuesday. The company has a 50 day moving average of $2.30 and a 200-day moving average of […] ....

United States , Mayne Pharma , Marland Walker , Therapeuticsmd Company Profile , Geode Capital Management , Therapeuticsmd Inc , Millennium Management , Tejara Capital Ltd , Charles Schwab Investment Management Inc , Free Report , Get Free Report , Capital Ltd , Schwab Investment Management , Capital Management , Nasdaq Txmd , Initiated Coverage , Stocknews Com ,

TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a hold rating on the stock. TherapeuticsMD Price Performance TXMD opened at $2.24 on Tuesday. TherapeuticsMD has a 52 week low of $1.95 and a 52 week high of $5.35. The business’s […] ....

United States , Mayne Pharma , Marland Walker , Jpmorgan Chase Co , Therapeuticsmd Inc , Securities Exchange Commission , Principal Financial Group Inc , Free Report , Get Free Report , Exchange Commission , Financial Group , Street Corp , Nasdaq Txmd , Initiated Coverage , Stocknews Com ,